Proteomic Profiling of MYCN-Associated Proteins in Neuroblastoma Revealed PKM2 as a Potential Therapeutic Target in MYCN Amplified Neuroblastoma

Wu Y.; Wu Z.

首页> 外文期刊>Pediatric blood & cancer >Proteomic Profiling of MYCN-Associated Proteins in Neuroblastoma Revealed PKM2 as a Potential Therapeutic Target in MYCN Amplified Neuroblastoma

【24h】

Proteomic Profiling of MYCN-Associated Proteins in Neuroblastoma Revealed PKM2 as a Potential Therapeutic Target in MYCN Amplified Neuroblastoma

机译：神经母细胞瘤中Mycn相关蛋白的蛋白质组学分析显示PKM2作为MyCN扩增神经母细胞瘤的潜在治疗靶标

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2018年第2期|共1页
作者
Wu Y.; Wu Z.;
展开▼
作者单位

Xinhua Hosp Pediat Surg Shanghai Peoples R China;

Xinhua Hosp Pediat Surg Shanghai Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. 11q23缺失在无MYCN基因扩增的骨髓转移神经母细胞瘤中预后不良 [J] . 岳志霞, 邢天禹, 高超, 癌症（英文版） . 2020,第003期
2. Proteomic Profiling of MYCN-Associated Proteins in Neuroblastoma Revealed PKM2 as a Potential Therapeutic Target in MYCN Amplified Neuroblastoma [J] . Wu Y., Wu Z. Pediatric blood & cancer . 2018,第Suppla2期

机译：神经母细胞瘤中Mycn相关蛋白的蛋白质组学分析显示PKM2作为MyCN扩增神经母细胞瘤的潜在治疗靶标
3. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma [J] . Eunjin Lee, Ji Won Lee, Boram Lee, BMC Medical Genomics . 2020,第1期

机译：神经母细胞瘤中免疫治疗性瘤的基因组谱和免疫治疗策略的潜力
4. A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins [J] . Sarra El-Soussi, Reine Hanna, Hanna Semaan, Frontiers in Pediatrics . 2021,第a期

机译：通过致瘤蛋白差异表达的IMIPRIDONES ONC201 / ONC206在MYCN扩增神经母细胞瘤细胞中的一种新疗效机理
5. COMPARISON OF POTENTIAL PREVENTIVE THERAPEUTIC AGENTS GREEN TEA, THYMOQUINONE, AND DILINOLEOYLPHOSPHATIDYLCHOLINE ON HUMAN NEUROBLASTOMA CELLS [C] . Kim Kennedy, Zelma Cason, Ham Benghuzzi, Annual rocky mountain bioengineering symposium;International ISA biomedical sciences instrumentation symposium . 2014

机译：潜在的预防性治疗剂对人神经母细胞瘤细胞绿茶，甲状腺素和二亚麻脂磷脂酰胆碱的比较
6. Quantitative Proteomic Analysis to Identify Differentiation Pathways Activated by a Potential Combination Therapy to Treat Neuroblastoma [D] . Halakos, Effie. 2020

机译：定量蛋白质组学分析，以鉴定潜在联合疗法激活的分化途径以治疗神经母细胞瘤
7. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma [O] . Eunjin Lee, Ji Won Lee, Boram Lee, 2020

机译：神经母细胞瘤中免疫治疗性瘤的基因组谱和免疫治疗策略的潜力
8. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma [O] . Eunjin Lee, Ji Won Lee, Boram Lee, 2020

机译：神经母细胞瘤中免疫治疗性瘤的基因组谱和免疫治疗策略的潜力

Proteomic Profiling of MYCN-Associated Proteins in Neuroblastoma Revealed PKM2 as a Potential Therapeutic Target in MYCN Amplified Neuroblastoma

著录项

相似文献

相关主题

期刊订阅